This narrative review aims to describe the emerging complex relationships between anemia, anemia-related factors, FGF-23, and other relevant molecules implicated in the pathogenesis of CKD-MBD, defining a “kidney–bone marrow–bone axis” (Figure 1). This evidence concerns the gene FGF23 and chronic kidney disease.